Clinical trial
High Plasma Level of Long Pentraxin 3 is Associated With Insulin Resistance in Women With Polycystic Ovary Syndrome
NCT01463969 is registered in ClinicalTrials.gov with Gulhane School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- High Plasma Level of Long Pentraxin 3 is Associated With Insulin Resistance in Women With Polycystic Ovary Syndrome
- Lead sponsor
- Gulhane School of Medicine
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2010
- Completion date
- May 31, 2011
- Enrollment
- 80 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
pcos